| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.03 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.04 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |